Essity AB Class A · OMXSTO:ESSITY_A

Essity AB Class A — Non-Deal Roadshow (February 2024)

27 slides from Essity AB Class A's roadshow presentation, Feb 6, 2024

  1. Slide 1: The Essity Group

    Slide 1: The Essity Group

    The Essity Group Fredrik Rystedt Executive Vice President and CFO

  2. Slide 2: Forward-looking statements

    Slide 2: Forward-looking statements

    This presentation may contain forward-looking statements. Such statements are based on our current expectations and are subject to certain risks and uncertainties that could negatively affect our business. Please read our most recent annual and sustainability report for a better understanding of the

  3. Slide 3: Oslo Roadshow with DNB February 6, 2024

    Slide 3: Oslo Roadshow with DNB February 6, 2024

    Oslo Roadshow with DNB February 6, 2024 3

  4. Slide 4: Essity – A Global, Leading Hygiene and Health Company

    Slide 4: Essity – A Global, Leading Hygiene and Health Company

    Essity – A Global, Leading Hygiene and Health Company Net sales 2023 147.1 SEKbn 18.9 Adjusted EBITA 2023 SEKbn 36,000 employees Oslo Roadshow with DNB 4

  5. Slide 5: Three Attractive Business Areas

    Slide 5: Three Attractive Business Areas

    Three Attractive Business Areas Health & Medical Consumer Goods Professional Hygiene Health & Medical Consumer Goods Professional Hygiene Personal and home hygiene Hygiene management for all stages of life solutions for a broad set of commercial applications Oslo Roadshow with DNB February 6, 2024 5

  6. Slide 6: Leading Global Market Positions

    Slide 6: Leading Global Market Positions

    Leading Global Market Positions Health & Medical Consumer Goods Professional Hygiene Incontinence Products Health Care #1 Incontinence Products Retail #2 Professional Hygiene #1 Compression Therapy #1 Consumer Tissue #3 Orthopedics #3 Feminine Care #5 Wound Care #5 Baby Care #5 Position #1 or #2 ~90

  7. Slide 7: Favorable Market Trends

    Slide 7: Favorable Market Trends

    Favorable Market Trends Growing and Aging Population Prevalence of Awareness about Chronic Conditions Text Increased Disposable Income Hygiene and Health Sustainability and Higher Living Standards Digitalization

  8. Slide 8: Key Achievements 2023

    Slide 8: Key Achievements 2023

    Key Achievements 2023 Highest profit ever and strong platform for growth Substantially improved structural margins for all business areas Good progress on key priorities – innovation, efficiency and sustainability Pre-conditional public offer announced for the shares in Vinda – enabling more attract

  9. Slide 9: Pre-conditional Public Offer Announced for 100% of Shares in Vinda

    Slide 9: Pre-conditional Public Offer Announced for 100% of Shares in Vinda

    Pre-conditional Public Offer Announced for 100% of Shares in Vinda Attractive offer yielding an annual return on the investment of approx. 14% at an EV/EBITDA multiple of 18.1x ▪ Isola Castle Ltd has announced that it will make a pre-conditional public offer to acquire 100% of Vinda for a price per

  10. Slide 10: Net Sales Split 2023

    Slide 10: Net Sales Split 2023

    Net Sales Split 2023 By Business Area and Category By Region Other, 4% Health & Asia, 2% Professional Medical, 19% Hygiene, 27% Incontinence Products Latin Health Care 11% Medical America, Solutions 17% 8% Europe, Baby Care 60% 5% Incontinence Consumer North Products Retail Tissue America, 7% Femini

  11. Slide 11: Long-term Portfolio Direction

    Slide 11: Long-term Portfolio Direction

    Long-term Portfolio Direction Health & Medical Professional Hygiene Consumer Personal Tissue Care Consumer Goods 11

  12. Slide 12: Value Creating Acquisitions

    Slide 12: Value Creating Acquisitions

    Value Creating Acquisitions Text

  13. Slide 13: Clear Long-term Financial Targets and Capital Allocation Priorities

    Slide 13: Clear Long-term Financial Targets and Capital Allocation Priorities

    Clear Long-term Financial Targets and Capital Allocation Priorities Maintain Annual sales growth1) Capital structure a solid >5% Baa1 long-term rating from investment grade rating Moody’s and BBB+ from S&P Adjusted return on capital employed2) Dividend >17% Dividend policy aiming for stable and risi

  14. Slide 14: 2023 - Strong Sales Growth, Record High Adjusted EBITA

    Slide 14: 2023 - Strong Sales Growth, Record High Adjusted EBITA

    2023 - Strong Sales Growth, Record High Adjusted EBITA Adjusted Adjusted +0.9% 147,147 EBITA2) EBITA Margin2) +9.5% Acquisitions SEK 12.8% 18,898m +360bps 131,320 -3.7% +57% Volume Price/Mix Adjusted Adjusted Earnings ROCE2) per Share3) Sales Growth1) +6.7% SEK 16.4% Net Sales Reported Growth: +12.1

  15. Slide 15: Strong Development of Sales and Profits

    Slide 15: Strong Development of Sales and Profits

    Strong Development of Sales and Profits Net Sales Adjusted EBITA1) SEKbn SEKbn +45% +65% 147.1 18.9 131.3 101.5 12.0 11.5 2021 2022 2023 2021 2022 2023 Sales Adjusted Growth2) +4.0% +19.7% +6.7% EBITA Margin1) +11.3% +9.2% +12.8% 1) Excluding items affecting comparability 2) Including organic sales

  16. Slide 16: Strong Development of Sales and Profits

    Slide 16: Strong Development of Sales and Profits

    Strong Development of Sales and Profits Net Sales Adjusted EBITA1) 18.9 147.1 17.6 SEKbn 131.3 SEKbn 129.0 15.8 118.5 121.8 109.3 13.4 12.9 98.5 101.2 101.5 12.0 11.5 12.0 88.0 10.6 9.5 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Adjusted Sales

  17. Slide 17: Dividend SEK 7.75

    Slide 17: Dividend SEK 7.75

    Dividend 7.751) 7.25 7.00 Proposed Dividend1) 6.75 6.25 5.75 SEK 7.75 +7% 2018 2019 2020 2021 2022 2023 1) Board of Directors Proposal Oslo Roadshow with DNB February 6, 2024 17

  18. Slide 18: Progress on Key Priorities

    Slide 18: Progress on Key Priorities

    Progress on Key Priorities 2023 Growth in Fastest Innovation & Growing Leading in Price Management Cost Efficiency Brands Categories and Sustainability Channels Science Based Targets +8.9% in Price +0.6% in Mix SEK 433m Inco Retail +14% Scope 1 and 2 vs 2016 Strong price effect while still Growth in

  19. Slide 19: Committed to Sustainable Solutions

    Slide 19: Committed to Sustainable Solutions

    Committed totoSustainable Committed Solutions andSolutions Sustainable Net Zero and Emissions by 2050 Net Zero Emissions by 2050 19

  20. Slide 20: Tork PeakServe with 20+ patents

    Slide 20: Tork PeakServe with 20+ patents

    Tork PeakServe with 20+ patents Highest 250% More capacity2 capacity on the market1 50% 1/2 Compression of towels Cut refill time in half2 1) Compared to competitor's longest roll towel in North America 2) Compared to Tork Universal refills and folded towel dispenser

  21. Slide 21: Feminine Care

    Slide 21: Feminine Care

    Feminine Care 21

  22. Slide 22: Accelerate Sustainable Solutions

    Slide 22: Accelerate Sustainable Solutions

    Accelerate Sustainable Solutions 3Rs 3Rs Reduce Reuse Recycle

  23. Slide 23: Superiority

    Slide 23: Superiority

    Superiority Share of Net Sales with Superiority 62% 56% 40% 2017 2020 2023 Oslo Roadshow with DNB

  24. Slide 24: Priorities 2024

    Slide 24: Priorities 2024

    Priorities 2024 Strong platform for growth ▪ Volume growth in high yielding segments Professional ▪ Innovation, brands and market shares gains Hygiene ▪ Price management ▪ Operational efficiency and digitalization ▪ Continued progress on ESG Oslo Roadshow with DNB

  25. Slide 25: Reasons to Invest in Essity

    Slide 25: Reasons to Invest in Essity

    Reasons to Invest in Essity Fundamentally attractive market Market leading brands Sustainability at the core Clear value creating strategy Attractive financial profile Proven execution Oslo Roadshow with DNB

  26. Slide 26: Q&A

    Slide 26: Q&A

    Q&A Text

  27. Slide 27

    Slide 27

Source: Internet Archive copy of essity.com

More decks from Essity AB Class A

All 40 Essity AB Class A decks